"ASSESSMENT OF EFFICACY OF VIRECHANOTTARA KSHEERAKALYANAKA GHRITA AND JATAMAMSI CHURNA IN THE MANAGEMENTOF ESSENTIALHYPERTENSIONWITH SPECIAL REFERENCE TO UCHCHA RAKTACHAPA.†–A COMPARATIVE STUDY
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 40
- 试验地点
- 1
- 主要终点
- Maintenance of Blood pressure to normal level
研究概览
简要总结
Hypertension is a syndrome with elevated blood pressure and modifiable risk factor for cardiovascular, cerebrovascular,renovascular disorders, prevalence increasing at an alarming rate, about 20-24% incidence rate. No direct reference of hypertension is found in ayurvedic texts but the symptoms of diseases like shirahshoola tridoshaja shiroroga unmad vatarakta Raktagata vata Dhamani Pratichaya shleshmavruta vata medoroga show the symptoms of essential hypertension. With a null hypothesis to know the effect of ksheerakalyanaka ghrita which will reduce atherosclerosis peripheral resistance shothahara unmadahara kaphamedahara action is selected. Jatamamsi is a potent aromatic herb known for its tranquilizing anti-convulsive and calming effect. Jatamamsi is Tridoshashamaka shothahara apasmaranashaka murchhahara nidrajanaka and shamaka. So classical drug as well as the single drug show unmadahara effect. Untreated, uncontrolled essential hypertension also mimics unmad. Therefore ksheerakalyanaka ghrita and jatamamsi churna have similar clinical pharmacology acting on Doshanulomana avaranaghna dhatusamyakara and manaprasadana. Hence present study entitled "Assessment of efficacy of Virechanottara ksheerakalyanaka ghrita and jatamamsi churna in the management of essential hypertension with special reference to uchcha raktachapa-A comparative study" is taken.
研究设计
- 研究类型
- Interventional
- 分配方式
- Coin toss, Lottery, toss of dice, shuffling cards etc
- 盲法
- Open Label
入排标准
- 年龄范围
- 30.00 Year(s) 至 65.00 Year(s)(—)
- 性别
- All
入选标准
- •Patients of Essential Hypertension / Stage I Hypertension.
- •Patients between the age group of 30-65 years.
排除标准
- •CCF EF<30% Multiorgan failure Pleural effusion Acute IHD/M.I C.R.F with Sr. Creatinine>8 mg/dl SEPSIS.
结局指标
主要结局
Maintenance of Blood pressure to normal level
时间窗: 6weeks
次要结局
- Correction of high blood pressure(Improvement in cardiac markers)
